Nomura Asset Management Co. Ltd. Acquires 11,769 Shares of Tenet Healthcare Corporation $THC

Nomura Asset Management Co. Ltd. boosted its holdings in Tenet Healthcare Corporation (NYSE:THC) by 823.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,199 shares of the company’s stock after buying an additional 11,769 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Tenet Healthcare were worth $2,623,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the business. Norges Bank bought a new position in Tenet Healthcare during the 4th quarter worth approximately $248,494,000. Eminence Capital LP acquired a new stake in shares of Tenet Healthcare during the 3rd quarter worth approximately $225,263,000. Boston Partners grew its position in shares of Tenet Healthcare by 38.8% during the 3rd quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after buying an additional 880,413 shares during the period. AQR Capital Management LLC grew its position in shares of Tenet Healthcare by 62.3% during the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock worth $380,989,000 after buying an additional 720,160 shares during the period. Finally, Alliancebernstein L.P. grew its position in shares of Tenet Healthcare by 375.7% during the 2nd quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock worth $139,085,000 after buying an additional 624,125 shares during the period. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Stock Performance

NYSE THC opened at $160.87 on Friday. The company has a fifty day simple moving average of $186.93 and a 200 day simple moving average of $201.02. Tenet Healthcare Corporation has a 12-month low of $146.60 and a 12-month high of $247.21. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. The company has a market cap of $13.86 billion, a P/E ratio of 8.37, a PEG ratio of 1.08 and a beta of 1.28.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.39 billion. During the same quarter last year, the firm posted $4.36 EPS. Tenet Healthcare’s revenue was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Sell-side analysts predict that Tenet Healthcare Corporation will post 17.67 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Tenet Healthcare news, EVP Paola M. Arbour sold 6,500 shares of the firm’s stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the transaction, the executive vice president directly owned 29,291 shares in the company, valued at approximately $6,983,853.13. This trade represents a 18.16% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Nadja West sold 3,000 shares of the firm’s stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total value of $532,050.00. Following the transaction, the director owned 24,805 shares in the company, valued at approximately $4,399,166.75. This trade represents a 10.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 23,138 shares of company stock valued at $4,976,589 in the last 90 days. Insiders own 0.97% of the company’s stock.

Wall Street Analyst Weigh In

THC has been the subject of several recent analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a research report on Wednesday, March 4th. Weiss Ratings downgraded shares of Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday. UBS Group raised their price objective on shares of Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. TD Cowen reissued a “buy” rating on shares of Tenet Healthcare in a research report on Thursday, February 12th. Finally, Robert W. Baird reduced their price target on shares of Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a research report on Tuesday, May 5th. Eighteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $244.16.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.